Evidence map›Paper›PMID 40168140›Full record

ArticleLiver international : official journal of the International Association for the Study of the Liver2025

How Secondary Interventions Reduce the Burden of Alcohol Consumption at Risk of Cirrhosis: A Public Health Decision-Making Model.

Claire Delacôte, Line Carolle Ntandja Wandji, Alexandre Louvet, Pierre Bauvin, Philippe Mathurin, Sylvie Deuffic-Burban

Abstract read
In one paragraph

Article in Liver international : official journal of the International Association for the Study of the Liver, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Claire DelacôteFaculté de Médecine, Université de Lille, Inserm, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.ORCID 0000-0002-8524-4770
Line Carolle Ntandja WandjiFaculté de Médecine, Université de Lille, Inserm, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.
Alexandre LouvetFaculté de Médecine, Université de Lille, Inserm, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.
Pierre BauvinFaculté de Médecine, Université de Lille, Inserm, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.
Philippe MathurinFaculté de Médecine, Université de Lille, Inserm, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.
Sylvie Deuffic-BurbanFaculté de Médecine, Université de Lille, Inserm, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBetter understanding of the kinetics of the consumption of alcohol at risk of cirrhosis (≥ 20 g/day) and the prediction of the burden of alcohol consumption are needed for public health decision-making.

methodsBased on individual data from 45 054 individuals, collected from the French Health, Health Care and Insurance Survey between 2002 and 2014, a Markov model was developed to predict the future burden of alcohol consumption ≥ 20 g/day. This estimated the incidence of alcohol intake with an intermediate (20-50 g/day) or high (≥ 50 g/day) risk of cirrhosis. The impact of five primary or secondary interventions was evaluated between 2024 and 2030.

resultsA 1 L increase in per capita alcohol consumption was associated with a 7% increase in the risk of progression to 20-50 g/day and to ≥ 50 g/day (HR = 1.07, 95% CI 1.06-1.07). Female gender was associated with a lower risk (HR = 0.47, 95% CI 0.43-0.51) and age < 45 years with a higher risk (HR = 4.15, 95% CI 2.60-6.63) of consuming ≥ 50 g/day. In 2023, 2.5 million French individuals aged 15-74 years old drank ≥ 20 g/day (5.5%), and 435 000 of these drank ≥ 50 g/day. Based on the status quo (SQ), this prevalence would be 5.1% in 2030, and would not be influenced by primary prevention, but would be reduced by secondary interventions (from -2.0% to -13.7% compared to the SQ depending on the rate of implementation).

conclusionsPrimary interventions are important to reduce the overall impact of alcohol on health. The strategy of targeting individuals who already drink ≥ 20 g/day of alcohol is more effective in reducing the short-term burden of alcohol consumption at risk of cirrhosis than primary interventions. Thus, primary and secondary interventions need to be implemented jointly.

Indexed as

Alcohol DrinkingLiver CirrhosisLiver Cirrhosis, AlcoholicSecondary PreventionAdolescentAdultAgedDecision Support TechniquesFemaleFranceHumansIncidenceMaleMarkov ChainsMiddle AgedPublic Healthalcohol consumptionalcohol‐related cirrhosisMarkov modelnationwide surveyprimary and secondary intervention

Identifiers

PMID40168140
PMCPMC11960838

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.